Diabetes medication use change
Vitamin D supplementation → Diabetes medication use change
Vitamin D supplementation → Diabetes medication use change
Evidence profile
Key finding
HOMA-IR decreased from 29.09 ± 36.56 to 16.54 ± 7.81 (P = 0.027)
This study investigated the effects of Vitamin K4 supplementation on insulin resistance and triglyceride levels in individuals with type 2 diabetes and found significant improvements.
Evidence strength
Moderate confidence
Study type
RCTs
Follow-up
Extended (5–20+ y)
Quick read
The essential study design details in one scan.
Population
Young Adult (19–39), Middle Aged (40-64), Male, Female, Asia-Pacific (APAC), with T2 Diabetes
Intervention
Vitamin K4 supplementation, Placebo
Study type
RCTs
Follow-up
Extended (5–20+ y)
Primary outcome
Homeostatic model assessment of insulin resistance (HOMA-IR)
Comparator
Placebo group
Plain-language summary
A plain-language read of the study's main message and where it applies.
Study focus
This study investigated the effects of Vitamin K4 supplementation on insulin resistance and triglyceride levels in individuals with type 2 diabetes and found significant improvements.
Improving insulin resistance and triglyceride levels is crucial for managing type 2 diabetes, as these factors are linked to cardiovascular health and overall metabolic function. The findings suggest that Vitamin K4 could be a beneficial adjunct therapy for individuals struggling to control their diabetes.
Limited sample size may affect generalizability Short duration of 24 weeks might not capture long-term effects No significant changes in fasting plasma glucose and HbA1c
Published in
Publication details and source links for this paper.
Amani MA, Maggie MA, Nirmeen AS, May F, Shrook M. Vitamin K4 supplementation for 24 weeks is capable of improving insulin resistance and TG levels in individuals with type 2 diabetes. European Journal of Nutrition. 2023;62(8):3241-3249. doi:10.1007/s00394-023-03215-8
Save this study and add notes to your research library.
HOMA-IR decreased from 29.09 to 16.54 (P = 0.027)
Fasting serum insulin decreased from 11.13 to 6.86 μU/ml (P = 0.032)
Triglycerides decreased from 172.8 to 144.94 mg/dl (P = 0.031)
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to Vitamin D supplementation and Diabetes medication use change, Fasting insulin levels, Insulin resistance, and 2 more.
This study contributes evidence to
Primary intervention
Vitamin D supplementation
Primary outcomes
Primary intervention
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
3
Related topics
5
Evidence pairs
355
Related studies
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Core evidence
The primary outcomes reported in this study.
Vitamin D supplementation → Diabetes medication use change
Vitamin D supplementation → Diabetes medication use change
Evidence profile
Vitamin D supplementation → Fasting insulin levels
Vitamin D supplementation → Fasting insulin levels
Evidence profile
Vitamin D supplementation → Insulin resistance
Vitamin D supplementation → Insulin resistance
Evidence profile
Vitamin D supplementation → Triglycerides
Vitamin D supplementation → Triglycerides
Evidence profile
Vitamin D supplementation → Very low-density lipoproteins (VLDL)
Vitamin D supplementation → Very low-density lipoproteins (VLDL)
Evidence profile
Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.
Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Vitamin D supplementation and HbA1c, Vitamin D supplementation and Adipokine and Angiogenic Markers.
This study contributes to the evidence on the following intervention-outcome relationships.
Curated evidence collections and hubs this study is part of.
All studies measuring HbA1c
Measures HbA1c as a key outcome.
All studies on Vitamin D supplementation
Contributes to Vitamin D supplementation evidence base.
All studies measuring Adipokine and Angiogenic Markers
Measures Adipokine and Angiogenic Markers as a key outcome.
Jump to pre-filtered views in the evidence archive.
5 results
1 results
5 results
5 results
1 results
Generated from the study's connected evidence using Evidence Intelligence™.
Vitamin D supplementation appears to improve Triglycerides.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Triglycerides
EvidenceScore™ Emerging | EvidenceScore™ 52.9 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Vitamin D supplementation appears to improve Very low-density lipoproteins (VLDL).
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Very low-density lipoproteins (VLDL)
EvidenceScore™ Emerging | EvidenceScore™ 52.9 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Vitamin D supplementation may improve Fasting insulin levels.
ConsensusScore™: Results are consistent across studies.
Ranked evidence signals
Fasting insulin levels
EvidenceScore™ Emerging | EvidenceScore™ 48.8 | weak positive | ConsensusScore™ Consistent | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Vitamin D supplementation may improve Insulin resistance.
ConsensusScore™: Results are mixed and should be interpreted cautiously.
Ranked evidence signals
Insulin resistance
EvidenceScore™ Emerging | EvidenceScore™ 48.8 | weak positive | ConsensusScore™ Mixed | 1 study
Why this answer: This answer is cautious because the available studies report mixed findings.
Limitations
Next steps
Choose a next path through related evidence topics, archive views, and research summaries.
Follow the topics this study contributes to.
Open broader archive views for this relationship.
Read related research summaries.
Focused on evidence, not advertising.
Your data is always protected.
New studies added every day.